Average cost of drugs for extensively drug-resistant tuberculosis in Zambia
Zambia: Average cost of drugs for extensively drug-resistant tuberculosis was 600 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
600 constant 2022 US$
Change on year
down 80.0%
World rank
49th
of 56 countries
All-time high
6,240 constant 2022 US$
in 2018
All-time low
600 constant 2022 US$
in 2024
Years of data
7
2018–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Zambia, 2018–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of drugs for extensively drug-resistant tuberculosis in Zambia stood at 600 constant 2022 US$. That is the lowest value across all 7 years on record.
Compared with earlier readings it is down 80.0% on the previous year and down 90.4% over ten years.
Zambia ranks 49th of 56 countries on this measure, in the bottom quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Zambia, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2018 | 6,240 constant 2022 US$ | — |
| 2019 | 6,240 constant 2022 US$ | +0.0% |
| 2020 | 6,240 constant 2022 US$ | +0.0% |
| 2021 | 6,240 constant 2022 US$ | +0.0% |
| 2022 | 3,000 constant 2022 US$ | -51.9% |
| 2023 | 3,000 constant 2022 US$ | +0.0% |
| 2024 | 600 constant 2022 US$ | -80.0% |
Zambia compared with similar countries
- Zambia's 600 constant 2022 US$ is below the median for lower middle income countries, which is 1,525 constant 2022 US$, 39% of the median. (24 countries reporting)
- Zambia's 600 constant 2022 US$ is below the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 40% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 6,240 constant 2022 US$ | 6,240 constant 2022 US$ | 6,240 constant 2022 US$ | 2 |
| 2020s | 3,816 constant 2022 US$ | 600 constant 2022 US$ | 6,240 constant 2022 US$ | 5 |
Countries ranked near Zambia
More reference data data for Zambia
- Exchange rate, new LCU per USD extended backward, period average 18.94 (2026)
- Exchange rate, old LCU per USD extended forward, period average 18.94 (2026)
- Official exchange rate, LCU per USD, period average 18.94 (2026)
- Political opposition, annual growth rate 0 % change on previous year (2025)
- Elected parliament and government, annual growth rate 0 % change on previous year (2025)
- Global number of reported disasters by size, gaps filled 0 events (2025)
- Annual precipitation, annual growth rate 40.84 % change on previous year (2025)
- Free country, gaps filled 1 (2025)
- Civil liberties rating, gaps filled 4 (2025)
- Civil liberties rating, annual growth rate 0 % change on previous year (2025)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Zambia?
- Average cost of drugs for extensively drug-resistant tuberculosis in Zambia was 600 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Zambia?
- The highest recorded value was 6,240 constant 2022 US$ in 2018.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Zambia?
- The lowest recorded value was 600 constant 2022 US$ in 2024.
- How does Zambia rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Zambia ranks 49th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Zambia?
- Over the last ten years it is down 90.4%. The long-run trend across the full record is falling.
- Where does this Zambia data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.